We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Wellcome Trust Sanger Institute Selects Geneservice to Provide Whole Genome Amplification
News

Wellcome Trust Sanger Institute Selects Geneservice to Provide Whole Genome Amplification

Wellcome Trust Sanger Institute Selects Geneservice to Provide Whole Genome Amplification
News

Wellcome Trust Sanger Institute Selects Geneservice to Provide Whole Genome Amplification

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Wellcome Trust Sanger Institute Selects Geneservice to Provide Whole Genome Amplification"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Geneservice Ltd has announced that the Wellcome Trust Sanger Institute has chosen Geneservice to provide whole genome amplification for circa 25,000 samples from multiple studies including the Wellcome Trust Case Control Consortium (WTCCC), EPIC (obesity), MalariaGen, and the International 1q type 2 diabetes consortium.

Expanding the amount of DNA available will allow multiple future experiments on these samples that have been collected over many years.

Evaluation of suppliers, was based on a common set of samples tested post-amplification with the Affymetrix™ Genechip as well as Illumina Golden Gate and Infinium technologies.

The selection of Geneservice was based on a combination of responsiveness, performance, quality of service and value for money.

Tom Weaver, CEO of Geneservice commented, "I am delighted that we have been awarded this prestigious project against strong international competition. Working with world class scientific teams and being entrusted to amplify their samples is a tribute to the dedicated Geneservice team."

Panos Deloukas of the Wellcome Trust Sanger Institute added, "We looked for a provider to work closely with us to develop robust protocols for these important projects."

Advertisement